Bloomberg News reports a prescription drug Donald Trump touted as a treatment for coronavirus, Hydroxychloroquine, was the focus of a small study that found it to be no more effective than conventional care.
The report published by the Journal of Zhejiang University in China showed that patients who got the medicine didn’t fight off the new coronavirus more often than those who did not get the medicine.
The study involved just 30 patients. Of the 15 patients given the malaria drug, 13 tested negative for the coronavirus after a week of treatment. Of the 15 patients who didn’t get hydroxychloroquine, 14 tested negative for the virus. The results of the study weren’t statistically significant.
Medical experts had said there was a chance the drug might have some efficacy against COVID-19 but insisted further testing was needed before being recommended.
After the Trumpster praised the medication saying he had a “good feeling” about the drug’s effectiveness and that it was “already approved by the FDA” experts stepped up to clarify that Hydroxychloroquine has only been approved to treat malaria and not coronavirus.
On Monday, the wife of an Arizona man who died after ingesting chloroquine phosphate (a version of the chemical) to protect himself from the novel coronavirus spoke out Monday to urge the public not to “believe anything” without first speaking to a healthcare professional.
“We saw Trump on TV — every channel — and all of his buddies and that this was safe,” the woman told NBC News. “Trump kept saying it was basically pretty much a cure.”